GSA CAPITAL PARTNERS LLP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 122 filers reported holding TG THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$191
-89.3%
22,857
-68.0%
0.02%
-91.0%
Q2 2023$1,777
+253.3%
71,518
+114.1%
0.18%
+256.0%
Q1 2023$503
-67.8%
33,411
-74.7%
0.05%
-74.2%
Q4 2022$1,560
-99.3%
131,893
+234.2%
0.19%
+525.8%
Q3 2022$234,000
+21.9%
39,466
-12.8%
0.03%
+6.9%
Q2 2022$192,000
-68.1%
45,281
-28.3%
0.03%
-64.2%
Q1 2022$601,000
+194.6%
63,184
+488.1%
0.08%
+211.5%
Q4 2021$204,000
-39.1%
10,744
+66.8%
0.03%
-52.7%
Q4 2020$335,000
-2.3%
6,442
-89.5%
0.06%
+19.6%
Q3 2019$343,00061,1150.05%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders